ANDISSO R7000 PRO Reciprocating Holder Dissolution Sampling System
| Brand | ANDISSO |
|---|---|
| Origin | Shanghai, China |
| Manufacturer Type | Authorized Distributor |
| Product Category | Domestic |
| Model | R7000 PRO |
| Instrument Type | Offline Sampling System |
| Vessel Configuration | 7-position × 6-row dissolution cups |
| Temperature Range | Ambient to 50 °C |
| Temperature Accuracy | ±0.2 °C |
Overview
The ANDISSO R7000 PRO Reciprocating Holder Dissolution Sampling System is an offline, programmable dissolution testing platform engineered for compliance with USP “Drug Release” and aligned with the physicochemical demands of complex extended-release and non-oral dosage forms. Unlike conventional paddle or basket apparatuses, the R7000 PRO implements reciprocating motion—vertical linear oscillation of sample holders within dissolution media—to generate controlled hydrodynamic shear stress, enabling reproducible simulation of physiological mechanical stimuli encountered by implants, transdermal patches, osmotic pumps, and matrix-based sustained-release tablets. Its architecture supports rigorous method development and validation under GLP-compliant laboratory environments, with thermal stability maintained across all 42 vessel positions (7 × 6 array) via independent PID-controlled heating modules.
Key Features
- USP -compliant reciprocating holder mechanism with adjustable stroke length (10–30 mm), frequency (5–30 cycles/min), and dwell time per cycle—fully programmable per vessel row
- Modular holder system accommodating five standardized USP geometries: spring-type (for matrix tablets), cylindrical (for transdermal patches), pointed-rod (for osmotic pumps), arterial (for vascular implants), and custom-configurable fixtures
- Offline sampling architecture with integrated peristaltic pump manifold, 42-channel filtration (0.45 µm PTFE), and timed fraction collection into chilled (4 °C) vial racks
- Independent temperature regulation per row (not per vessel), achieving ±0.2 °C accuracy across ambient to 50 °C operating range—validated per USP thermal mapping protocols
- Robust stainless-steel frame with IP54-rated electronics enclosure; CE-marked power supply and IEC 61000-4 EMC compliance
Sample Compatibility & Compliance
The R7000 PRO is validated for use with solid oral dosage forms requiring mechanical agitation beyond standard USP Apparatus 1–4, including hydrophilic matrix tablets, enteric-coated multiparticulates, bilayer osmotic systems, silicone-based transdermal delivery devices, and bioresorbable polymeric implants. It meets critical regulatory expectations for dissolution method transfer and compendial equivalence: full traceability to USP , alignment with Ph. Eur. 2.9.3 “Release Testing of Transdermal Systems”, and compatibility with FDA Guidance for Industry on Extended-Release Dosage Forms (2018). All firmware and control logic are designed to support audit-ready documentation per 21 CFR Part 11 requirements—including electronic signatures, operator-level access control, and immutable event logs.
Software & Data Management
The system operates via ANDISSO Dissolution Suite v3.2—a Windows-based application supporting method creation, real-time motion parameter monitoring, automated sampling scheduling, and raw data export in ASTM E1953-compliant .csv and .xlsx formats. The software includes built-in validation tools for cycle timing verification, temperature drift analysis, and sampling volume calibration reports. Audit trails record all user actions—including method edits, start/stop commands, and calibration events—with timestamps, operator IDs, and reason-for-change fields. Data integrity safeguards include automatic backup to network drives, SHA-256 hash verification of archived batches, and optional integration with LIMS via HL7 v2.5 or RESTful API endpoints.
Applications
- Development and QC release testing of osmotic push-pull tablets (e.g., nifedipine OROS® analogs)
- In vitro-in vivo correlation (IVIVC) studies for transdermal fentanyl and buprenorphine patches under dynamic fluid exchange conditions
- Stability-indicating dissolution profiling of biodegradable PLGA microspheres and subcutaneous implants
- Comparative evaluation of erosion-driven vs. diffusion-controlled release mechanisms in pH-sensitive hydrogels
- Regulatory submission support for ANDA and NDA filings requiring USP methodology justification
FAQ
Is the R7000 PRO suitable for continuous online UV detection?
No—the R7000 PRO is strictly an offline sampling system. Integration with online UV spectrophotometers requires third-party flow-cell interfaces and is not supported out-of-the-box.
Can vessel temperature be monitored individually per cup?
Temperature is regulated and verified per row (6 rows × 7 vessels), not per individual cup. Thermal uniformity across each row is validated per USP using calibrated PT100 probes.
Does the system support GMP-compliant electronic records?
Yes—when deployed with Dissolution Suite v3.2 and configured with role-based authentication, audit trail logging, and digital signature workflows, it satisfies ALCOA+ principles and 21 CFR Part 11 Subpart C requirements.
What maintenance intervals are recommended for the reciprocating drive mechanism?
Lubrication of linear guide rails and timing belt inspection are required every 500 operational hours; full motion calibration is advised quarterly or after any mechanical impact event.
Are replacement holders available for non-USP geometries?
ANDISSO provides custom engineering services for application-specific holder designs, subject to NDA and mechanical feasibility review—lead time typically 8–12 weeks.
